Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Peter Rindom Koffeldt

3PUBLICATIONS
6CO-AUTHORS
Solid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jul 12, 2025
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced <i>ALK</i>-Rearranged NSCLC.

Edyta Maria Urbanska, Peter Rindom Koffeldt, Morten Grauslund

|Oct 21, 2024
ALK-tyrosine kinase inhibitor intrinsic resistance due to <i>de novo</i> <i>MET</i>-amplification in metastatic <i>ALK</i>-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report.

Edyta M Urbanska, Morten Grauslund, Siv M S Berger

|Sep 09, 2023
Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo <i>MET</i> Amplification in Patients with Metastatic <i>EGFR</i>-Mutated NSCLC.

Edyta M Urbanska, Morten Grauslund, Peter R Koffeldt

Pageof 1

Frequent Collaborators

3 joint publications

Edyta Maria Urbanska

3 joint publications

Jens Benn Sørensen

3 joint publications

Eric Santoni-Rugiu

2 joint publications

Morten Grauslund

1 joint publications

Siv M S Berger

1 joint publications

Junia C Costa

Frequent Collaborators

3 joint publications

Edyta Maria Urbanska

3 joint publications

Jens Benn Sørensen

3 joint publications

Eric Santoni-Rugiu

2 joint publications

Morten Grauslund

Top Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on : Sep 08, 2023

1.2K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.8K
See more related videos

Top Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on : Sep 08, 2023

1.2K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.8K
See more related videos